Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older. - Mileshkin, L. R.; Seymour, J. F.; Wolf, M. M.; Gates, P.; Januszewicz, E. H.; Joyce, P.; Prince, H. M. (Leukemia & Lymphoma, 2005)